1272 EG Huizen
PharmaPlus is an independent consulting firm focused on early stage licensing deals (preclinical/phase I/II) for pharmaceutical and biotechnology products.
Global services range from identification of potential marketable technologies to market scans, active partner search services and deal negotiation support.
PharmaPlus is known for it’s unparalleled partner search services focused on therapeutic products.
Based on the client’s specifications, PharmaPlus uses its in-house proprietary partner search databases and its broad network to identify potential partners.
Through PharmaDeal Financials (www.pharmadealfinancials.com) PharmaPlus offers quick and affordable access to financial information on therapeutic license deals. PharmaDeal Financials are unique searchable thematic licensing databases.
The databases for specific disease areas, indications, compound classes and big pharma and big biotech focus on financial deal specifics (as far as available) for therapeutics over the last 12 years, including potential deal size, upfront, milestone payments, royalties on sales, research funding and equity.